|
|
||||||||
American Journal of Clinical Nutrition, Vol 61, 1186-1194, Copyright © 1995 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
SA Beshyah, C Freemantle, E Thomas and DG Johnston
Unit of Metabolic Medicine, St. Mary's Hospital Medical School, Paddington, London.
We compared fat-free mass (FFM) and percentage body fat mass (BFM) values derived from total body potassium (TBK), bioelectrical impedance analysis (BIA), and dualenergy X-ray absorptiometry (DXA) in hypopituitary adults before and after 6 mo treatment with growth hormone. Before growth hormone treatment, FFM values from the three methods correlated strongly. FFM values from TBK were lower than FFM values derived from BIA and DXA (mean +/- SD: 53.7 +/- 14.3 compared with 49.1 +/- 9.2 kg, P < 0.0001; DXA compared with TBK: 54.7 +/- 16.4 and 49.2 +/- 9.7 kg, P < 0.0002). BFM values from TBK were significantly higher than the BIA-derived (P < 0.002) but not different from the DXA-derived values. There was no difference in FFM and BFM values derived from DXA and BIA methods. The differences between BIA and TBK methods and between DXA and TBK methods were observed in the obese but not in the nonobese subjects. The increase in FFM derived from BIA with growth hormone was greater than that derived from TBK ([median(range)]; BIA: +5.2(-0.1, +13.8) compared with TBK: +0.9(-4.8, +8.6) kg, P < 0.001, but the changes with placebo were not different. The changes in FFM and BFM derived from DXA was growth hormone and placebo were not significantly different from those derived by using TBK or BIA. We conclude that FFM and BFM values derived from TBK, BIA, and DXA correlate highly and that TBK-derived values for FFM are lower than those derived from BIA and DXA in obese patients.
This article has been cited by other articles:
![]() |
M Sood, J E Adams, and M Z Mughal Lean body mass in children with cystic fibrosis Arch. Dis. Child., September 1, 2003; 88(9): 836 - 836. [Full Text] |
||||
![]() |
W. Arlt, F. Callies, I. Koehler, J. C. van Vlijmen, M. Fassnacht, C. J. Strasburger, M. J. Seibel, D. Huebler, M. Ernst, M. Oettel, et al. Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4686 - 4692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ahmad, R. Guzder, A. M. Wallace, J. Thomas, W. D. Fraser, and J. P. Vora Circadian and Ultradian Rhythm and Leptin Pulsatility in Adult GH Deficiency: Effects of GH Replacement J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3499 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-W. Chu, K. S. L. Lam, S. C. F. Tam, W. J. H. C. Hu, S.-L. Hui, A. Chiu, K.-C. Chiu, and P. Ng A Randomized Controlled Trial of Low-Dose Recombinant Human Growth Hormone in the Treatment of Malnourished Elderly Medical Patients J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1913 - 1920. [Abstract] [Full Text] |
||||
![]() |
F. Callies, M. Fassnacht, J. C. van Vlijmen, I. Koehler, D. Huebler, M. J. Seibel, W. Arlt, and B. Allolio Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency: Effects on Body Composition, Serum Leptin, Bone Turnover, and Exercise Capacity J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1968 - 1972. [Abstract] [Full Text] |
||||
![]() |
A. Chrisoulidou, S. A. Beshyah, O. Rutherford, T. J. Spinks, J. Mayet, P. Kyd, V. Anyaoku, A. Haida, B. Ariff, M. Murphy, et al. Effects of 7 Years of Growth Hormone Replacement Therapy in Hypopituitary Adults J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3762 - 3769. [Abstract] [Full Text] |
||||
![]() |
D. P Kotler, D. M Thea, M. Heo, D. B Allison, E. S Engelson, J. Wang, R. N Pierson Jr, M. S. Louis, and G. T Keusch Relative influences of sex, race, environment, and HIV infection on body composition in adults Am. J. Clinical Nutrition, March 1, 1999; 69(3): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |